Avid Bioservices Inc (CDMO)

[pphmtoolong]

Geo, I see some posters have shown that other companies have provided more detailed information on patient enrollment in their clinical trials. That's nice.

However, I am a shareholder of Peregrine. I feel entitled to as much information as Peregrine can provide that is consistent with the orderly operation of the company. I am not concerned with the "industry standard" in such matters unless it serves a purpose that is consistent with the well-being of the company and my interests as an investor.

If the company has good news, it will make us happy and might even boost the share price. How this benefits some unidentified potential competitor is a mystery to me. With all due modesty I am a highly intelligent person and a generalized reference to some "competitive advantage" this gives some other company sounds lame.

I do not ask for specific numbers, but an "about this fraction" or "over this percentage" would help us correlate the publicly available sites open to the actual progress of the trial.

GLTA, Paul